Cart 0

MarketsandMarkets

Pharmaceutical Membrane Filtration Market- Global Forecast to 2021

$5,650.00

Report Published By: MarketsandMarkets
Publication Date : Jan-17
No. Of Pages: 142

The global pharmaceutical membrane filtration market is expected to reach USD 6.20 billion by 2021 from USD 3.55 billion in 2016, at a CAGR of 11.8% from 2016 to 2021. Growth in the biopharmaceutical industry and advancements in the nanofiltration technology are the key factors driving the growth of the market. On the other hand, strict government regulations for validation of the filtration process and low adoption of membrane filters in emerging markets due to cost constraints are the major factors restraining the growth of this market
Factors such as increase in the growth of biopharmaceutical industry and rapid growth in generic drug production are driving the global pharmaceutical Filtration market. However stringent government regulations for validation of the filtration process hindering the growth of this market.
The global pharmaceutical membrane filtration market has been segmented on the basis of type of products, technique, application, and region.
On the basis of product, the pharmaceutical membrane filtration market is segmented into MCE membrane filters, coated cellulose acetate membrane filters, nylon membrane filters, PTFE membrane filters, PVDF membrane filters, and other membrane filters. The MCE membrane filters segment is expected to account for the largest and fastest-growing segment of the global pharmaceutical membrane filtration market in 2016. The large share of this segment is primarily attributed to the increasing adoption of different types of membrane filters for various filtration applications and the frequent use of these filters as compared to prefilters, single-use systems, and cartridges & capsules. The increasing focus of the pharmaceutical industries can also lead to the adoption rate of biopharmaceutical industry has resulted in the increase in demand for pharmaceutical membrane Filtration products.
Based on product, the pharmaceutical membrane filtration market is segmented into MCE, coated cellulose, nylon, PTFE membrane, PVDF membrane, other membrane. The MCE membrane product is estimated to witness the highest CAGR during the forecast period, 2016 to 2021. Due to high production of pharmaceutical products and drugs, MCE attributes the largest share.
Based on technique, the pharmaceutical membrane filtration market has beenis segmented into microfiltration, nano filtration, crossfiltration, ultrafiltration, reverse osmosis, and ion exchange. The microfiltration segment is anticipated expected to grow at the highest CAGR during the forecast period.from 2016 to 2021. The high adoption of microfiltration over other techniques in pharmaceutical applications accounts for the large share of this segment. The high growth in this segment is due to the rising demand the research and medical services.
On the basisBased on application, the global pharmaceutical membrane filtration market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification, Processing, Raw material filtration. The final product processing segment is further classified into active pharmaceutical ingredient filtration, sterile filtration, protein purification, vaccine and & antibody processing, formulation and & filling solutions, and viral clearance. Among the applications, The final product processing segment is expected to witness the highest growth rate during the forecast period, due to advancement of Nano-filtration.
Geographically, the market is segmented into four regions, namely, North America, Europe, Asia, and RoW. and rest of the world (ROW). The global pharmaceutical membrane filtration market is dominated by North America, followed by Europe. The growth of this market is mainly driven by the growth in the pharmaceutical industry, increasing incidence of airborne disease, rapid expansion of generics production, and advancements in nanofiber technology.
Growth in the North American region is due to the increasing in incidence of airborne diseases which will boost the growth of this market. Also, R&D growth and spending on pharmaceutical and biotechnology projects and the rising number of drug development projects are important drivers for the pharmaceutical filtration market in North America. Besides this, the large size of the North American biotechnology industry is expected to continue to drive the growth of the pharmaceutical filtration market in this region. .
The major players in the global pharmaceutical membrane filtration market include Merck KGaA (Germany), GE Healthcare Company (U.K.), Pall Corporation (U.S.), Sartorius Stedim Biotech Group (France), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), and GEA Group (Germany).Merck KGaA (Germany), General Electric Company (U.S.), Pall Corporation (U.S.), Sartorius Stedim Biotech Group (France), ALFA LAVAL (Sweden), Graver Technologies, LLC (U.S.), Koch membrane system (U.S.), and GEA Group (Germany).
Research Coverage
This report aims to provide insights on the global pharmaceutical membrane filtration market. It provides valuable information on the type of product, technique, application, and regionsnal segments of the global pharmaceutical filtration market. The report also covers the market dynamics which includes the drivers, restraints, opportunities and challenges of the global pharmaceutical membrane filtration market. This report covers the competitive landscape of the top ten companies in the global pharmaceutical membrane filtration market. The competitive landscape includes a comparison between the companies and the strategies adopted by them in order to continue their presence in the Pharmaceutical membrane filtration market.

Value Addition for the Buyer:
The above mentioned information would benefit buyers by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize on the growth opportunities. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years.
In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above mentioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output, in order to remain successful in the global pharmaceutical membrane filtration market.

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 14
1.3.1 MARKET COVERED 14
1.3.2 YEARS CONSIDERED IN THE REPORT 15
1.4 CURRENCY 15
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 MARKET SIZE ESTIMATION 18
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 21
2.3 MARKET SHARE ESTIMATION 22
2.3.1 KEY DATA FROM SECONDARY SOURCES 22
2.3.2 KEY DATA FROM PRIMARY SOURCES 22
2.3.3 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 30
4.1 GLOBAL PHARMACEUTICAL MEMBRANE FILTRATION MARKET OVERVIEW 30
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 MARKET DRIVERS 35
5.2.1.1 Growth in the biopharmaceutical industry 35
5.2.1.2 Advancements in the nanofiltration technology 35
5.2.1.3 Growing application in the control of airborne diseases 36
5.2.1.4 Significant rise in generic drug production 36
5.2.1.5 Strong biologics pipeline 36
5.2.2 MARKET RESTRAINTS 37
5.2.2.1 Strict government regulations for validation of the filtration process 37
5.2.2.2 Low adoption of membrane filters in emerging markets due to cost constraints 38
5.2.3 MARKET OPPORTUNITIES 38
5.2.3.1 Growth potential in emerging markets 38
?
5.2.4 CHALLENGES 40
5.2.4.1 Intense competition in the market is a critical entry barrier for new entrants 40
5.2.5 TRENDS 40
5.2.5.1 Rising adoption of single-use technologies 40
6 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT 41
6.1 INTRODUCTION 42
6.2 MCE MEMBRANE FILTERS 44
6.3 COATED CELLULOSE ACETATE 45
6.4 NYLON 46
6.5 PTFE MEMBRANE 47
6.6 PVDF MEMBRANE 48
6.7 OTHER MEMBRANE FILTERS 49
7 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE 50
7.1 INTRODUCTION 51
7.2 MICROFILTRATION 53
7.3 ULTRAFILTRATION 54
7.4 NANOFILTRATION 55
7.5 REVERSE OSMOSIS 56
7.6 ION EXCHANGE 57
8 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION 58
8.1 INTRODUCTION 59
8.2 FINAL PRODUCT PROCESSING 60
8.3 RAW MATERIAL FILTRATION 61
8.4 AIR PURIFICATION 63
8.5 CELL SEPARATION 64
8.6 WATER PURIFICATION 65
9 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION 66
9.1 INTRODUCTION 67
9.2 NORTH AMERICA 68
9.2.1 U.S. 73
9.2.2 CANADA 76
9.3 EUROPE 79
9.4 ASIA 82
9.5 REST OF THE WORLD (ROW) 86
?
10 COMPETITIVE LANDSCAPE 90
10.1 INTRODUCTION 90
10.2 STRATEGIC ANALYSIS 91
10.3 MARKET SHARE ANALYSIS 92
10.4 COMPETITIVE SITUATION AND TRENDS 93
10.4.1 PRODUCT LAUNCHES AND UPGRADES 94
10.4.2 MERGERS & ACQUISITIONS 95
10.4.3 AGREEMENTS AND COLLABORATIONS 96
10.4.4 EXPANSIONS 97
10.4.5 OTHER DEVELOPMENTS 98
11 COMPANY PROFILES 99
(Overview, Products and Services, Financials, Strategy & Development)*
11.1 INTRODUCTION 99
11.2 MERCK KGAA 100
11.3 GENERAL ELECTRIC COMPANY 104
11.4 DANAHER CORPORATION (PALL CORPORATION) 107
11.5 SARTORIUS STEDIM BIOTECH S.A. 111
11.6 3M COMPANY 114
11.7 ALFA LAVAL 117
11.8 GRAVER TECHNOLOGIES, LLC 120
11.9 KOCH MEMBRANE SYSTEM 122
11.10 GEA GROUP 124
11.11 NOVASEP 127
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
12 APPENDIX 129
12.1 INSIGHTS OF INDUSTRY EXPERTS 129
12.2 DISCUSSION GUIDE 130
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 133
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 135
12.5 AVAILABLE CUSTOMIZATIONS 137
12.6 RELATED REPORTS 138
12.7 AUTHOR DETAILS 139
LIST OF TABLES

TABLE 1 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SUMMARY 25
TABLE 2 GROWTH IN THE BIOPHARMACEUTICAL INDUSTRY IS PROPELLING THE GROWTH OF THE PHARMACEUTICAL MEMBRANE FILTRATION MARKET 37
TABLE 3 STRINGENT GOVERNMENT REGULATIONS FOR VALIDATION OF THE FILTRATION PROCESS ARE EXPECTED TO RESTRICT MARKET GROWTH 38
TABLE 4 RISING OPPORTUNITIES IN THE EMERGING MARKETS TO BOOST THE GROWTH OF THE PHARMACEUTICAL MEMBRANE FILTRATION MARKET 39
TABLE 5 INTENSE COMPETITION ACTS AS AN ENTRY BARRIER FOR NEW ENTRANTS 40
TABLE 6 RISING ADOPTION OF SINGLE-USE TECHNOLOGIES IS A MAJOR TREND FOR MARKET PLAYERS 40
TABLE 7 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 43
TABLE 8 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR MCE (NITROCELLULOSE), BY REGION, 2014–2021 (USD MILLION) 44
TABLE 9 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR COATED CELLULOSE ACETATE, BY REGION, 2014–2021 (USD MILLION) 45
TABLE 10 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR NYLON BY REGION, 2014–2021 (USD MILLION) 46
TABLE 11 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR PTFE MEMBRANE, BY REGION, 2014–2021 (USD MILLION) 47
TABLE 12 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR PVDF MEMBRANE, BY REGION, 2014–2021 (USD MILLION) 48
TABLE 13 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR OTHER MEMBRANE FILTERS, BY REGION, 2014–2021 (USD MILLION) 49
TABLE 14 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY TECHNIQUE,
2014–2021 (USD MILLION) 52
TABLE 15 PHARMACEUTICAL MICROFILTRATION MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 53
TABLE 16 PHARMACEUTICAL ULTRAFILTRATION MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 54
TABLE 17 PHARMACEUTICAL NANOFILTRATION MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 55
TABLE 18 PHARMACEUTICAL REVERSE OSMOSIS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 56
TABLE 19 PHARMACEUTICAL ION EXCHANGE MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 57
TABLE 20 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 59
TABLE 21 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR FINAL PRODUCT PROCESSING, BY TYPE, 2014–2021 (USD MILLION) 60
TABLE 22 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR FINAL PRODUCT PROCESSING, BY REGION, 2014–2021 (USD MILLION) 61
TABLE 23 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR RAW MATERIAL FILTRATION, BY TYPE, 2014–2021 (USD MILLION) 62
TABLE 24 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR RAW MATERIAL FILTRATION, BY REGION, 2014–2021 (USD MILLION) 62
TABLE 25 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR AIR PURIFICATION, BY REGION, 2014–2021 (USD MILLION) 63
TABLE 26 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR CELL SEPARATION, BY REGION, 2014–2021 (USD MILLION) 64
TABLE 27 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR WATER PURIFICATION, BY REGION, 2014–2021 (USD MILLION) 65
TABLE 28 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 67
TABLE 29 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE,
BY REGION, 2014–2021 (USD MILLION) 70
TABLE 30 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE,
BY PRODUCT, 2014–2021 (USD MILLION) 71
TABLE 31 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE,
BY TECHNIQUE, 2014–2021 (USD MILLION) 71
TABLE 32 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE,
BY APPLICATION, 2014–2021 (USD MILLION) 72
TABLE 33 NORTH AMERICA: FINAL PRODUCT PROCESSING MARKET SIZE,
BY SUBSEGMENTS, 2014–2021 (USD MILLION) 72
TABLE 34 NORTH AMERICA: RAW MATERIAL APPLICATION, 2014–2021 (USD MILLION) 73
TABLE 35 U.S.: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 74
TABLE 36 U.S.: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 74
TABLE 37 U.S.: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 75
TABLE 38 U.S. FINAL PRODUCT PROCESSING MARKET SIZE, BY SUBSEGMENTS,
2014–2021 (USD MILLION) 75
TABLE 39 U.S.: RAW MATERIAL APPLICATION, 2014–2021 (USD MILLION) 76
TABLE 40 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 76
TABLE 41 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE,
BY TECHNIQUE, 2014–2021 (USD MILLION) 77
TABLE 42 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE,
BY APPLICATION, 2014–2021 (USD MILLION) 77
TABLE 43 CANADA. FINAL PRODUCT, 2014–2021 (USD MILLION) 78
TABLE 44 CANADA: RAW MATERIAL APPLICATION, 2014–2021 (USD MILLION) 78
TABLE 45 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE,
BY TECHNIQUE, 2014–2021 (USD MILLION) 79
TABLE 46 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE,
BY TECHNIQUE, 2014–2021 (USD MILLION) 80
TABLE 47 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE,
BY APPLICATION, 2014–2021 (USD MILLION) 80
TABLE 48 EUROPE: FINAL PRODUCT, 2014–2021 (USD MILLION) 81
TABLE 49 EUROPE: RAW MATERIAL APPLICATION, 2014–2021 (USD MILLION) 81
TABLE 50 ASIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 84
TABLE 51 ASIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 84
TABLE 52 ASIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 85
TABLE 53 ASIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE,
BY FINAL PRODUCT, 2014–2021 (USD MILLION) 85
TABLE 54 ASIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE,
BY RAW MATERIAL APPLICATION, 2014–2021 (USD MILLION) 86
TABLE 55 ROW: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 87
TABLE 56 ROW: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 87
TABLE 57 ROW: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 88
TABLE 58 ROW : PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE,
BY FINAL PRODUCT, 2014–2021 (USD MILLION) 88
TABLE 59 ROW: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE,
BY RAW MATERIAL APPLICATION, 2014–2021 (USD MILLION) 89
TABLE 60 MARKET DEVELOPMENTS BETWEEN JANUARY 2013 AND JUNE 2016 93
TABLE 61 PRODUCT LAUNCHES AND UPGRADES, 2013–2016 94
TABLE 62 MERGERS & ACQUISITIONS, 2013–2016 95
TABLE 63 AGREEMENTS AND COLLABORATIONS, 2013–2016 96
TABLE 64 EXPANSIONS, 2013–2016 97
TABLE 65 OTHER DEVELOPMENTS, 2013–2016 98

* indicates required information

* indicates required information


Share this Product


More from this collection